Search Results - "Lebdai, S"

Medium-term Follow-up of Vascular-targeted Photodynamic Therapy of Localized Prostate Cancer Using TOOKAD Soluble WST-11 (Phase II Trials) by Noweski, A., Roosen, A., Lebdai, S., Barret, E., Emberton, M., Benzaghou, F., Apfelbeck, M., Gaillac, B., Gratzke, C., Stief, C., Azzouzi, A.R.

“…To assess the medium-term tumor control in patients with localized prostate cancer (PCa) treated with vascular-targeted photodynamic (VTP) therapy with TOOKAD…”
Get full text

Vascular targeted photodynamic therapy in low-risk prostate cancer. A literature review by Kleinclauss, F, Frontczak, A, Balssa, L, Lebdai, S, Azzouzi, R

“…Currently, about 50% of newly prostate cancers are localized and low-risk according to D'Amico risk classification. Focal therapies whose objective is to treat…”
Get more information

Management of benign prostate hyperplasia by Lebdai, S, Descazeaud, A

“…Benign prostatic hyperplasia is a frequent pathology in men after 50years old. It is responsible for lower urinary tract symptoms (LUTS). These LUTS might have…”
Get more information

Double J stenting evaluation after ureteroscopy for urolithiasis by Segalen, T, Lebdai, S, Panayotopoulos, P, Culty, T, Brassart, E, Riou, J, Azzouzi, A R, Bigot, P

“…During ureteroscopy for urolithiasis, postoperative ureteral drainage with double J stent is frequently used. It may reduce acute postoperative pain and late…”
Get more information

Impact of partial nephrectomy in a hybrid operating room on the activity of kidney cancer surgery by Aubert, C, Rolley, C, Mauny, M, Heuveline, J, Silve, E, Humeau, M, Le Corre, V, Lebdai, S, Brassart, E, Culty, T, Baize, N, Rousselet, M C, Nedelcu, C, Aubé, C, Bouvier, A, Bigot, P

“…Partial nephrectomy (NP) after embolization of tumor vessels (NPESH) in a hybrid room combines embolization of tumor vessels and enucleation of the tumor under…”
Get more information

Perioperative and economic analysis of surgical treatments for benign prostatic hyperplasia: A study of the French committee on LUT by Mathieu, R, Lebdai, S, Cornu, J N, Benchikh, A, Azzouzi, A R, Delongchamps, N B, Dumonceau, O, Faix, A, Fourmarier, M, Haillot, O, Lukacs, B, Misrai, V, de La Taille, A, Robert, G, Descazeaud, A

“…To evaluate perioperative cost related to surgical treatments of benign prostatic obstruction (BPO): photoselective vaporization of the prostate (pvp),…”
Get more information

Evaluation of bleeding risk in patients on anticoagulation for mechanical cardiac valve operated for benign prostatic obstruction by Gardic, S, Misrai, V, Azzouzi, A R, Campeggi, A, Cornu, J-N, Taille, A De La, Lebdai, S, Mathieu, R, Robert, G, Descazeaud, A

“…To evaluate bleeding risk in patients on anticoagulation for mechanical cardiac valve operated for benign prostatic obstruction (BPO). Fifty-eight patients…”
Get more information

Treatment of localized prostate cancer by vascular-targeted photodynamic therapy with WST11 by Lebdai, S, Martin, F, Bigot, P, Azzouzi, A R

“…Focal therapies are new options for the treatment of localized prostate cancer. Vascular-targeted photodynamic therapy (VTP) with WST11 is one of these…”
Get more information

Post-treatment MRI aspects of photodynamic therapy for prostate cancer by Kulik, M., Nedelcu, C., Martin, F., Lebdai, S., Rousselet, M. C., Azzouzi, A. R., Aubé, C.

“…Objectives Photodynamic therapy is a new focal therapy for prostate cancer. Methods In this technique, a photosensitising agent is introduced intravenously,…”
Get full text

Prostate cancer and new hormonal treatments: mechanism of action and main clinical results by Neuzillet, Y, Flamand, V, Lebdai, S, Villers, A, Lebret, T

“…New drugs have recently been developed, through a better understanding of the mechanisms involved in the progression of prostate cancer, including…”
Get more information

Clinical impact of the intravesical prostatic protrusion: a review by the LUTS committee of the French Urological Association by Lebdai, S, Ammi, M, Bigot, P, Cornu, J-N, Mathieu, R, Descazeaud, A, Azzouzi, A-R

“…Intravesical prostatic protrusion (IPP) is a protrusion of the lateral and/or median prostatic lobes into the bladder lumen. IPP can be estimated by suprapubic…”
Get more information

Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia by Descazeaud, A, Barry Delongchamps, N, Cornu, J-N, Azzouzi, A R, Buchon, D, Benchikh, A, Coloby, P, Dumonceau, O, Fourmarier, M, Haillot, O, Lebdai, S, Mathieu, R, Misrai, V, Saussine, C, de La Taille, A, Robert, G

“…To establish a guide dedicated to general practitioner for the diagnosis, the follow-up, and the treatment of lower urinary tract symptoms (LUTS) related to…”
Get more information

Do postoperative drainage types modify outcomes after retrograde intrarenal surgery? by Cerruti, A, Lebdai, S, Martin, F, Hoarau, N, Chautard, D, Culty, T, Azzouzi, A R, Bigot, P

“…The aim of the current study was to evaluate if the postoperative drainage type modified the outcomes after retrograde flexible ureteroscopy (f-URS) and…”
Get more information

Medicoeconomic aspects of benign prostatic hyperplasia medical treatment by Lebdai, S, Azzouzi, A R, Delongchamps, N-B, Benchikh, A, Campeggi, A, Cornu, J-N, Dumonceau, O, Faix, A, Fourmarier, M, Haillot, O, Lukacs, B, Mathieu, R, Misrai, V, Robert, G, de La Taille, A, Descazeaud, A

“…The medicoeconomic issues of drug management of benign prostatic hyperplasia (BPH) are essential due to the aging population and the increasing number of…”
Get more information

Corticotherapy in castration-resistant prostate cancer by Lebdai, S, Branchereau, J, Robert, G, De La Taille, A, Bouchaert, P

“…Corticosteroids are commonly used in the treatment of prostate cancer resistant to castration (PCRC), partly due to the inhibitory effects on adrenal androgen…”
Get more information

Initial assessment of male non-neurogenic incontinence: systematic review of the literature by the LUTS committee of the French Urological Association by Mathieu, R, Benchikh, A, Azzouzi, A R, Campeggi, A, Cornu, J N, Delongchamps, N B, Dumonceau, O, Faix, A, Fourmarier, M, Haillot, O, Lebdai, S, Lukacs, B, Misrai, V, Robert, G, de La Taille, A, Descazeaud, A

“…To perform an update on the initial evaluation of male urinary incontinence (MUI). A systematic review was conducted using Pubmed/Medline from 1995 to 2013…”
Get more information

Editorial comment to: Urinary PCA3 to predict prostate cancer in a cohort of 1015 patients by Bigot, P, Lebdai, S, Azzouzi, A R

Get more information

Evaluation of the impact of CTMH guidelines on the management of benign prostatic hyperplasia by Lebdai, S, Rahmène Azzouzi, A, Delongchamps, N B, Benchikh, A, Campeggi, A, Cornu, J N, Dumonceau, O, Faix, A, Fourmarier, M, Haillot, O, Lukacs, B, Mathieu, R, Misrai, V, Robert, G, de La Taille, A, Descazeaud, A

“…The French guidelines on the management of benign prostatic hyperplasia (BPH) have been published in 2012 by the LUTS committee of the French Urological…”
Get more information

Conservative treatment of male non-neurologic urinary incontinence: a review by the LUTS committee of the French Urological Association by Lebdai, S, Delongchamps, N B, Azzouzi, A R, Benchikh, A, Campeggi, A, Cornu, J-N, Dumonceau, O, Faix, A, Fourmarier, M, Haillot, O, Lukacs, B, Mathieu, R, Misrai, V, Robert, G, de La Taille, A, Descazeaud, A

“…To perform an update on the conservative treatment of male non-neurologic urinary incontinence. A systematic review was conducted using PubMed/MEDLINE with the…”
Get more information

Research fellowship in the curriculum of French urologists-in-training: a study by the French Association of Urologists-in-training (AFUF) by Rizk, J, Audenet, F, Brichart, N, Capon, G, Dariane, C, Fiard, G, Lebdai, S, Madec, F-X, Maurin, C, Sanson, S, Tanchoux, C, Thibault, F, Murez, T, Terrasa, J-B, Terrier, J-É

“…To assess motivations, the practical organization and the funding of a research fellowship in the training curriculum of French urologists-in-training. An…”
Get more information